Navigation Links
Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations

CENTENNIAL, Colo., April 13, 2011 /PRNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced the hire of Angela Horacek as the Vice President, Operations.

In this role Horacek, a seasoned medical device and operations expert, will oversee the broad range of AlloSource operations including donor receiving and medical records clearance, as well as tissue processing and release.

"It is with great pleasure that we welcome Angela to the AlloSource Executive Leadership Team, where her industry experience, strategic operational thought process and exceptional rapport with people will be great assets for our organization," said Thomas Cycyota, president and CEO of AlloSource. "We are dedicated to advancing the possibilities of tissue transplantation to better serve patients and honor the brave gift of life from donors and their families, and Angela's expertise will help us support this goal."

Horacek comes to AlloSource from nSpire Health, a leading developer and manufacturer of respiratory care products, where she was most recently the Global Vice President of Operations and Quality.  In this role, Horacek was responsible for manufacturing, supply chain, logistics, facilities and quality and regulatory services for three facilities around the world. Prior to her role at nSpire Health, she held positions of increasing responsibility in operations for several medical device and pharmaceutical organizations.  

Horacek holds a bachelor's degree in chemical engineering, a MBA from the University of Louisiana in Lafayette, and a master's degree in Conflict Resolution from the University of Denver.

AlloSource, a nonprofit organization and one of the nation's premier tissue networks, has provided a range of tissue allografts including bone, skin and joint grafts to its local communities around the country for more than fifteen years. The Company has recently expanded into osteobiologics offerings, which help to stimulate natural bone formation, and has pioneered the use of mesenchymal stem cells derived from donor adipose tissue for orthopedic applications. AlloSource has facilitated approximately 100,000 live stem cell transplants worldwide, becoming the world's largest provider of stem cell tissue for surgeries.  

About AlloSource

AlloSource delivers powerful possibilities to the medical community, patients and donor families. AlloSource is a non-profit company that offers more than 200 precise bone, skin, soft-tissue and custom-machined allografts for use in a host of life-saving and life-enhancing medical procedures. As the world's leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has become one of the largest and most respected tissue networks in the country. It is also the world's largest processor of live cellular bone growth substitutes. AlloSource delivers unparalleled expertise and responsive customer service to its growing network of surgeons, partners and the country's most reputable organ procurement organizations. AlloSource is accredited by the American Association of Tissue Banks (AATB) and operates in Centennial, CO. For more information, visit

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Thomas Cycyota

SOURCE AlloSource
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
(Date:11/25/2015)...  The American Academy of Pediatrics (AAP), American ... March of Dimes cheered today,s signature into law ... of 2015 (S.799), which takes much-needed strides ... to drugs, such as opioids, and to improve ... organizations have worked together leading advocacy efforts for ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Henry Schein, ... and services to office-based dental, medical and animal health ... (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion , ... broadest array of open solutions designed to help any ... Click here for a schedule of experts ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology:
(Date:11/26/2015)... (PRWEB) , ... November 26, ... ... online platform for mental health and wellness consultation, has collaborated with Women’s ... holistically address their reader’s queries on topics on mental and emotional well-being ...
(Date:11/25/2015)... ... ... The holiday season is jam-packed with family dinners, parties ... is of the utmost importance. Whether you are cooking at home for the ... try this holiday season. , Turkey Croquettes ,     Ingredients: , ...
(Date:11/25/2015)... ... 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever ... with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the ... the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is ...
(Date:11/25/2015)... Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... da Vinci surgical robot is being more and more widely heralded as a breakthrough ... assisted da Vinci method has over traditional laparoscopic surgery is that it can greatly ...
(Date:11/25/2015)... ... 25, 2015 , ... Wimbledon Health Partners, the industry leader ... Athletics Facebook page to educate the public, parents and school athletic departments ... people under the age of 25 die from sudden cardiac arrest every year. ...
Breaking Medicine News(10 mins):